LIBERTY CORNER, N.J., Jan. 30 /PRNewswire/ -- Reliant Pharmaceuticals, Inc. today announced that Bradley T. Sheares, Ph.D., the company’s Chief Executive Officer, will present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on Tuesday, February 6 at 1:00 PM Eastern. The conference is being held at the Grand Hyatt Hotel in New York.
Dr. Sheares will provide an overview of Reliant and an update on the company’s product portfolio.
About Reliant Pharmaceuticals, Inc.
Reliant Pharmaceuticals is a pharmaceutical company with integrated sales, marketing and development expertise that markets a portfolio of branded cardiovascular pharmaceutical products. Reliant focuses on marketing promotionally sensitive pharmaceutical products to the high prescribing primary care, cardiovascular and specialist physician markets in the United States. Reliant also acquires rights to and develops product candidates in mid- to late-stage clinical development. Reliant’s sales force infrastructure is comprised of approximately 825 sales professionals nationwide.
“Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995. To the extent any statements made in this release contain information that is not historical, these statements are essentially forward looking and are subject to risks and uncertainties, including the difficulty of predicting FDA approvals, acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, new product development and launch, reliance on key strategic alliances, availability of raw materials, the regulatory environment, fluctuations in operating results and other risks.
Reliant Pharmaceuticals, Inc.
CONTACT: Marylou Rowe, Investor Relations Manager, ReliantPharmaceuticals, Inc., +1-908-860-4646, investorrelations@reliantrx.com
Web site: http://www.reliantrx.com/
